查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1362886

血栓管理設備市場規模、佔有率和趨勢分析報告：按產品、最終用途、地區和細分趨勢，2023-2030 年

Clot Management Devices Market Size, Share & Trends Analysis Report By Product (Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices), By End-use (Diagnostic Centers, Hospitals), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

血栓管理設備市場成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，到 2030 年，全球血栓管理設備市場規模預計將達到 25.3 億美元，預測期內年複合成長率為 5.0%。

市場成長受到多種要素的推動，例如心血管疾病患病的增加、老年人口的增加以及醫療技術的進步。醫療專業人員和患者對有效血栓管理在預防嚴重健康併發症方面的好處的認知不斷提高，也推動了對這些設備的需求。

心血管疾病罹患率的上升也刺激了市場需求。隨著人口高齡化，與血栓形成相關的危險因子不斷增加，凸顯了有效解決方案的必要性。醫療保健提供者正在尋求先進的設備來解決日益增加的心血管疾病負擔並降低凝血相關的風險。血栓管理設備的技術進步也推動了市場的成長。導管、過濾器和支架等創新技術正在開發中，以提高凝塊回收和溶解能力。該領域最尖端科技的不斷開拓正在推動採用率並推動市場成長。

COVID-19大流行對市場產生了強烈影響，提高了人們對與病毒相關的血液凝固風險增加的認知。醫療保健提供者擴大利用血塊取出設備來治療患有嚴重肺部病變和血栓相關併發症的COVID-19 患者，從而改善患者的治療結果。提高對血栓管理重要性的認知可能會對優先考慮預防和管理凝血相關併發症的衛生系統產生長期影響。隨著醫療保健提供者應對大流行帶來的挑戰並優先考慮全面的患者照護，市場預測持續成長。

血栓管理設備市場報告亮點

  • 從按產品來看，2022年經皮取栓設備的銷售佔有率最大。這是因為它用於微創手術中去除血栓，這對患者和醫療保健提供者都有吸引力。此細分市場的主導地位也歸功於技術進步，例如創新設備的開發和血栓清除效率的提高，導致對經皮血栓除去裝置。
  • 根據最終用途，血栓管理設備市場分為診斷中心和醫院。 2022 年，醫院業務佔收益佔有率最大。該醫院將作為需要血栓管理的患者的初級保健中心，提供初步評估、診斷和治療建議。醫院有專門的委員會和團隊來選擇醫療設備，並與價值鏈中的各個營業單位合作取得血栓管理設備。
  • 預計北美地區將在 2022 年以 59.73% 的最大收益佔有率主導市場。北美擁有發達、先進的醫療基礎設施，包括醫院、診所和醫療設施。此外，心血管疾病患病的上升和高齡化進一步推動了北美的產品需求。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 市場變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 市場趨勢及展望
  • 市場動態
    • 心血管疾病患病增加
    • 醫療科技的進步
    • 有效血栓切除術/栓塞設備的需求增加
  • 市場抑制因素分析
    • 設備成本高
    • 意識和培訓有限
  • 營商環境分析
    • SWOT 分析；要素因素（政治/法律、經濟/技術）
    • 波特五力分析
  • COVID-19感染疾病的影響分析

第4章 血栓管理設備市場：產品細分分析

  • 血栓管理設備：2022 年和 2030 年市場佔有率分析
  • 神經血管栓塞裝置
  • 用於清除栓塞的球囊導管
  • 經皮栓裝置
  • 導管定向溶栓（CDT）裝置
  • 大靜脈篩檢程式(IVCF)

第5章 血栓管理設備市場：最終用途細分分析

  • 血栓管理設備：2022 年和 2030 年市場佔有率分析
  • 診斷中心
  • 醫院

第6章 血栓管理設備市場：區域分析

  • 2022 年及 2030 年血栓管理設備市場佔有率（按地區）
  • 北美洲
    • 北美血栓管理設備市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲血栓管理設備市場，2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區血栓管理設備市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲血栓管理設備市場，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 2018-2030年中東及非洲血栓管理設備市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 公司分類
  • 策略規劃
  • 2022 年公司市場佔有率分析
  • 公司簡介/名單
    • Medtronic
    • Boston Scientific Corporation
    • iVascular SLU
    • Teleflex Inc
    • Edwards Lifesciences Corporation
    • LeMaitre Vascular, Inc
    • Vascular Solutions, Inc
    • Straub Medical AG
    • Cook Medical
    • DePuy Synthes
Product Code: GVR-1-68038-201-3

Clot Management Devices Market Growth & Trends:

The global clot management devices market size is expected to reach USD 2.53 billion by 2030, advancing at a CAGR of 5.0% during the forecast period, according to a new report by Grand View Research, Inc.. The market growth is driven by several factors, including an increase in the prevalence of cardiovascular diseases, a rise in geriatric population, and advancements in medical technology. The demand for these devices is also fueled by the growth in awareness among healthcare professionals and patients regarding the benefits of effective clot management in preventing serious health complications.

The rising incidence of cardiovascular diseases has fueled market demand. As the population ages, the risk factors associated with blood coagulum formation increase, highlighting the need for effective solutions. Healthcare providers are seeking advanced devices to address the growing burden of CVDs and mitigate coagulum-related risks. Technological advancements in clot management devices have also driven market growth. Innovations such as catheters, filters, and stents are being developed to enhance coagulum retrieval and dissolution capabilities. Continued development of cutting-edge technologies in the field has boosted adoption rates and propelled market growth.

The COVID-19 pandemic strongly impacted the market by raising awareness of the increased blood coagulum risk associated with the virus. Healthcare providers have increasingly utilized clot retrieval devices to treat COVID-19 patients with severe lung involvement and clot-related complications, improving patient outcomes. Increased awareness of clot management's importance is poised to have long-lasting effects on healthcare systems prioritizing the prevention and management of coagulum-related complications. The market is poised to witness sustained growth as healthcare providers address challenges posed by the pandemic and prioritize comprehensive patient care.

Clot Management Devices Market Report Highlights:

  • Based on product, the percutaneous thrombectomy devices segment held the largest revenue share in 2022, as it is used in minimally invasive procedures for removing blood clots, which appeals to both patients and healthcare providers. The segment's dominance can also be attributed to advancements in technology, such as the development of innovative devices and improved efficacy in clot removal, leading to higher adoption rates and demand for percutaneous thrombectomy devices
  • Based on end-use, the market for clot management devices has been categorized into diagnostic centers and hospitals. The hospitals segment accounted for the largest revenue share in 2022. Hospitals serve as the primary point of care for patients requiring clot management, providing initial evaluation, diagnosis, and treatment recommendations. They have dedicated committees and teams for selecting medical devices and collaborating with different entities in the value chain to access clot management devices
  • The North American region accounted for the largest revenue share of 59.73% in 2022 and is expected to dominate the market. North America has a well-developed, advanced healthcare infrastructure, including hospitals, clinics, and medical facilities; additionally, the rising prevalence of cardiovascular diseases and an aging population further drive product demand in North America

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information Or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Increasing Prevalence of cardiovascular diseases
    • 3.4.2. Advancements In Medical Technology
    • 3.4.3. Increasing Demand for Effective Thrombectomy/Embolectomy Devices
  • 3.5. Market Restraint Analysis
    • 3.5.1. High device cost
    • 3.5.2. Limited awareness and training
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.6.2. Porter's Five Forces Analysis
  • 3.7. COVID-19 Impact Analysis

Chapter 4. Clot Management Devices Market: Product Segment Analysis

  • 4.1. Clot Management Devices: Market Share Analysis, 2022 & 2030
  • 4.2. Neurovascular Embolectomy Devices
    • 4.2.1. Neurovascular Embolectomy Devices Market, 2018 - 2030 (USD Million)
  • 4.3. Embolectomy Balloon Catheters
    • 4.3.1. Embolectomy Balloon Catheters Market, 2018 - 2030 (USD Million)
  • 4.4. Percutaneous Thrombectomy Devices
    • 4.4.1. Percutaneous Thrombectomy Devices Market, 2018 - 2030 (USD Million)
    • 4.4.2. Aspiration Thrombectomy Devices
      • 4.4.2.1. Aspiration Thrombectomy Devices market, 2018 - 2030 (USD Million)
    • 4.4.3. Percutaneous Mechanical Thrombectomy Devices
      • 4.4.3.1. Percutaneous Mechanical Thrombectomy Devices market, 2018 - 2030 (USD Million)
  • 4.5. Catheter-Directed Thrombolysis (CDT) Devices
    • 4.5.1. Catheter-Directed Thrombolysis (CDT) Devices Market, 2018 - 2030 (USD Million)
  • 4.6. Inferior Vena Cava Filters (IVCF)
    • 4.6.1. Inferior Vena Cava Filters (IVCF) MARKET, 2018 - 2030 (USD MILLION)

Chapter 5. Clot Management Devices Market: End-Use Segment Analysis

  • 5.1. Clot Management Devices: Market Share Analysis, 2022 & 2030
  • 5.2. Diagnostic Centers
    • 5.2.1. Diagnostic Centers Market, 2018 - 2030 (USD Million)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market, 2018 - 2030 (USD Million)

Chapter 6. Clot Management Devices Market; Regional Analysis

  • 6.1. Clot Management Devices Market Share By Region, 2022 & 2030
  • 6.2. North America
    • 6.2.1. North Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Competitive Scenario
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. U.S. Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Canada Clot Management Devices Market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. UK Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Germany Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. France Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Italy Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Spain Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Denmark Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Sweden Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Norway Clot Management Devices Market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Japan Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. China Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. India Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Australia Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Thailand Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. South Korea Clot Management Devices Market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Brazil Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Mexico Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.5.4. Argentina
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Argentina Clot Management Devices Market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. South Africa Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Saudi Arabia Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. UAE Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Kuwait Clot Management Devices Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Share Analysis, 2022
  • 7.4. Company Profiles/Listing
    • 7.4.1. Medtronic
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Boston Scientific Corporation
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. iVascular SLU
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Teleflex Inc
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Edwards Lifesciences Corporation
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. LeMaitre Vascular, Inc
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Vascular Solutions, Inc
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Straub Medical AG
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Cook Medical
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. DePuy Synthes
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 Global clot management devices market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America clot management devices market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 7 North America clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe clot management devices market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 UK clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 UK clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 Germany clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 18 Germany clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 France clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 France clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Italy clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 Italy clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Spain clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Spain clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Denmark clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 26 Denmark clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Sweden clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Sweden clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Norway clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 30 Norway clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific clot management devices market, by country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Japan clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 35 Japan clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 China clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 37 China clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 India clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 39 India clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Australia clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 41 Australia clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Thailand clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 43 Thailand clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 South Korea clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 45 South Korea clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Latin America clot management devices market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 48 Latin America clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Brazil clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 50 Brazil clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Mexico clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 52 Mexico clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Argentina clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 54 Argentina clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa clot management devices market, by country, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 South Africa clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 59 South Africa clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 UAE clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 63 UAE clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Kuwait clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 65 Kuwait clot management devices market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 Market formulation & validation
  • FIG. 7 Clot management devices market segmentation
  • FIG. 8 Market snapshot, 2022
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market driver relevance analysis (current & future impact)
  • FIG. 11 Market restraint relevance analysis (current & future impact)
  • FIG. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • FIG. 13 Porter's five forces analysis
  • FIG. 14 Market penetration & growth prospect mapping, 2022
  • FIG. 15 Global clot management devices market: Product movement analysis
  • FIG. 16 Global clot management devices market, for neurovascular embolectomy devices, 2018 - 2030 (USD Million)
  • FIG. 17 Global clot management devices market, for embolectomy balloon catheters, 2018 - 2030 (USD Million)
  • FIG. 18 Global clot management devices market, for percutaneous thrombectomy devices, 2018 - 2030 (USD Million)
  • FIG. 19 Global clot management devices market, for catheter-directed thrombolysis (CDT) devices, 2018 - 2030 (USD Million)
  • FIG. 20 Global clot management devices market, for inferior vena cava filters (IVCF), 2018 - 2030 (USD Million)
  • FIG. 21 Global clot management devices market: End user movement analysis
  • FIG. 22 Global clot management devices market, for diagnostic centers, 2018 - 2030 (USD Million)
  • FIG. 23 Global clot management devices market, for hospitals, 2018 - 2030 (USD Million)
  • FIG. 24 Regional marketplace: Key takeaways
  • FIG. 25 Regional outlook, 2022 & 2030
  • FIG. 26 Global clot management devices market: Regional movement analysis
  • FIG. 27 North America clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 28 U.S. clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 29 Canada clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 30 Europe clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 31 Germany clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 32 UK clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 33 France clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 34 Italy clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 35 Spain clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 36 Denmark clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 37 Sweden clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 38 Norway clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 39 Asia Pacific clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 40 Japan clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 41 China clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 42 India clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 43 Australia clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 44 South Korea clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 45 Thailand clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 46 Latin America clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 47 Brazil clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 48 Mexico clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 49 Argentina clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 50 Middle East and Africa clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 51 South Africa clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 52 Saudi Arabia clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 53 UAE clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 54 Kuwait clot management devices market, 2018 - 2030 (USD Million)